Related Experiment Video
Updated: Dec 1, 2025
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.4K
Identification of a Novel Substrate-Derived Spermine Oxidase Inhibitor
T T Dunston1, M A Khomutov2, S B Gabelli1,3,4
1Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 USA.
Acta Naturae
|November 11, 2020
Summary
Researchers identified a novel spermine analogue, 2,11-Met2-Spm, as a potential inhibitor for spermine oxidase (SMOX). This finding offers a new tool for studying polyamine metabolism and its role in diseases like cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cellular polyamine homeostasis, involving spermine (Spm) and spermidine (Spd), is crucial for cell growth and viability.
- Spermine oxidase (SMOX) is a key enzyme regulating polyamine homeostasis by converting Spm to Spd.
- SMOX is induced by inflammation, a factor in epithelial cancer development, making it a potential therapeutic target.
Purpose of the Study:
- To investigate spermine analogues as potential inhibitors of SMOX.
- To identify novel tools for studying polyamine catabolism and its role in disease.
Main Methods:
- Enzyme inhibition assays were performed using the novel compound 1,12-diamino-2,11-bis(methylidene)-4,9-diazadodecane (2,11-Met2-Spm).
- The inhibitory activity of 2,11-Met2-Spm against SMOX was quantified under standard assay conditions.
Main Results:
- The novel compound 2,11-Met2-Spm demonstrated an IC50 value of 169 μM against SMOX.
- This compound shows potential as an instrument and lead for studying polyamine catabolism.
Conclusions:
- 2,11-Met2-Spm represents a promising lead compound for developing SMOX inhibitors.
- Further research into this analogue could advance understanding of polyamine metabolism in cancer and other inflammatory diseases.
